GLI1 and acute promyelocytic leukemia: The antagonistic effects of ATO are achieved by ATO binding directly to the GLI zinc fingers, which is similar to the domain of promyelocytic leukemia–retinoic acid receptor α in APL, leading to the transcriptional inactivation of GLI (21).